Marketwire -- MALVERN, PENNSYLVANIA, AND STAFFORD, UK, 3 November 2008 - PuriCore (LSE: PURI), the life sciences company focused on developing and commercialising proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens, announces that on 1 November 2008 Darren Weiss, VP Finance, was granted options (the “Options”) over 100,000 Ordinary Shares of 1p each in the Company (“Ordinary Shares”) under the PuriCore plc Executive Omnibus Incentive Plan. The Options are to vest in amounts of one-third of the total grant per year over three years, exercisable from the date of vesting until the fifth anniversary of the date of grant at an exercise price of 10.25 pence per share.
